Compuestos orgánicos

Mesilato de casmostato, o un solvato del mismo, para el tratamiento de fibrosis quística. The invention describes novel pharmaceutically acceptable salt forms of camostat, processes for lyophilisation, taste-masked formulations, nebulised formulations and the use of each of the fore-going in the tre...

Full description

Saved in:
Bibliographic Details
Main Authors SINGH, DILRAJ, MAAS, JANET C, TULLY, DAVID, MONNIER, STEPHANIE, HEUERDING, SILVIA, REBER, JEAN-LOUIS, HARRIS, JENNIFER, ROETTELE, JUERGEN, DANAHAY, HENRY L, LEGRAND, DARREN M
Format Patent
LanguageSpanish
Published 17.10.2012
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Mesilato de casmostato, o un solvato del mismo, para el tratamiento de fibrosis quística. The invention describes novel pharmaceutically acceptable salt forms of camostat, processes for lyophilisation, taste-masked formulations, nebulised formulations and the use of each of the fore-going in the treatment of respiratory diseases, particularly cystic fibrosis and chronic obstructive pulmonary disease (COPD).
Bibliography:Application Number: ES20060742574T